49,446 Shares in Ryan Specialty Holdings Inc. $RYAN Purchased by Y Intercept Hong Kong Ltd

Key Points

• Y Intercept Hong Kong Ltd opened a new position in Ryan Specialty Holdings, buying 49,446 shares valued at about $1.67 million in the first quarter.
• Institutional ownership remains very high, with hedge funds and other large investors holding 84.82% of the company. Several firms, including Goldman Sachs and UBS AM, increased their stakes during the quarter.
• Ryan Specialty has seen a mix of solid fundamentals and shareholder-return actions: it beat quarterly earnings expectations, issued a dividend, approved a $300 million share buyback, and recently had insider share purchases from its chairman and a director.

Y Intercept Hong Kong Ltd acquired a new position in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 49,446 shares of the company's stock, valued at approximately $1,668,000.

Several other large investors have also modified their holdings of RYAN. Royal Bank of Canada raised its holdings in shares of Ryan Specialty by 10.6% in the first quarter. Royal Bank of Canada now owns 59,639 shares of the company's stock worth $4,406,000 after buying an additional 5,739 shares during the period. AQR Capital Management LLC boosted its holdings in Ryan Specialty by 25.1% during the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company's stock valued at $367,000 after acquiring an additional 998 shares during the period. Goldman Sachs Group Inc. grew its position in Ryan Specialty by 46.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company's stock valued at $27,787,000 after acquiring an additional 119,055 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Ryan Specialty by 11.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company's stock valued at $24,586,000 after acquiring an additional 33,667 shares during the last quarter. Finally, Creative Planning increased its stake in Ryan Specialty by 15.4% in the second quarter. Creative Planning now owns 4,586 shares of the company's stock worth $312,000 after purchasing an additional 613 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Analyst Ratings Changes

Several analysts have recently weighed in on RYAN shares. Piper Sandler decreased their target price on Ryan Specialty from $43.00 to $35.00 and set a "neutral" rating for the company in a research report on Friday, May 1st. Keefe, Bruyette & Woods raised their price target on shares of Ryan Specialty from $44.00 to $48.00 and gave the stock an "outperform" rating in a research note on Wednesday. Mizuho raised their price target on shares of Ryan Specialty from $35.00 to $39.00 and gave the stock a "neutral" rating in a research note on Thursday. Cantor Fitzgerald lifted their price objective on shares of Ryan Specialty from $33.00 to $34.00 and gave the company a "neutral" rating in a report on Thursday. Finally, UBS Group lowered their price objective on shares of Ryan Specialty from $52.00 to $50.00 and set a "buy" rating for the company in a research report on Wednesday. Eight equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $48.59.

Ryan Specialty Stock Performance

Shares of RYAN stock opened at $40.59 on Friday. Ryan Specialty Holdings Inc. has a 12-month low of $29.28 and a 12-month high of $67.69. The business's fifty day simple moving average is $34.53 and its 200-day simple moving average is $39.40. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 2.90. The company has a market cap of $10.70 billion, a PE ratio of 52.72, a PEG ratio of 0.99 and a beta of 0.61.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The firm had revenue of $795.23 million for the quarter, compared to the consensus estimate of $781.44 million. During the same period in the previous year, the business earned $0.39 EPS. The firm's revenue for the quarter was up 15.2% on a year-over-year basis. Analysts expect that Ryan Specialty Holdings Inc. will post 2.05 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.13 per share. The ex-dividend date was Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.3%. Ryan Specialty's payout ratio is presently 67.53%.

Ryan Specialty announced that its board has approved a stock buyback program on Tuesday, May 26th that authorizes the company to buyback $300.00 million in shares. This buyback authorization authorizes the company to purchase up to 3.5% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's management believes its stock is undervalued.

Insider Transactions at Ryan Specialty

In related news, Chairman Patrick G. Ryan bought 120,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $32.50 per share, for a total transaction of $3,900,000.00. Following the purchase, the chairman directly owned 13,817,859 shares of the company's stock, valued at approximately $449,080,417.50. This trade represents a 0.88% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director John W. Rogers, Jr. bought 7,500 shares of the company's stock in a transaction on Wednesday, June 10th. The shares were bought at an average cost of $35.16 per share, for a total transaction of $263,700.00. Following the transaction, the director owned 117,933 shares in the company, valued at $4,146,524.28. The trade was a 6.79% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have acquired 130,715 shares of company stock worth $4,263,590. Insiders own 52.03% of the company's stock.

Trending Headlines about Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Keefe, Bruyette & Woods raised its price target on Ryan Specialty to $48 from $44 and kept an outperform rating, signaling continued upside potential. Benzinga report
• Positive Sentiment: UBS lifted its target to $50 from $52 and reiterated a buy rating, suggesting analysts still see meaningful upside from current levels. Benzinga report
• Neutral Sentiment: Ryan Specialty announced that Nirvana will acquire certain assets of its Swedish subsidiary, a transaction that appears to be a limited portfolio change rather than a major companywide shift. Article link

Ryan Specialty Company Profile

Ryan Specialty Group, Inc NYSE: RYAN is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.

Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.